Preoperative gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy

Journal of B.U.ON.

Volumn 18, Issue 4, 2013, Pages 954-960

  Acimovic, M ^a,b   Dabic Stankovic, K ^a,b   Pejcic, T ^a,b   Dzamic, Z ^a,b   Rafailovic, D ^a,b   Hadzi Djokic, J ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b NONE   (Serbia)

Author keywords

Biochemical recurrence; Prediction; Prostate cancer; PSA; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; PATIENT MONITORING; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; SERBIA;

ADENOCARCINOMA; BIOPSY; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; HUMANS; KALLIKREINS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SERBIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893114154     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy:results at 10 years. J Urol 1994;152 (5 Pt 2):1831-1836. (Pubitemid 24322640)
2. Heidenreich A, Bolla M, Joniau S et al. Guidelines on Prostate Cancer;European Association of Urology, 2011.
3. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients:long term results. J Urol 2004;172:910-914. (Pubitemid 39096421)
4. Freedland SJ, Terris MK, Csathy GS et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 2004:171 (6 Ptl):2215-2220. (Pubitemid 38625437)
5. Pierorazio PM, Walsh PC, Partin AW et al. Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology 2010;76:715-721.
6. Pierorazio PM, Walsh PC, Partin AW et al. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy. BJU Int 2012;110:1122-1128.
7. Freedland SJ, Aronson WJ, Terris MK et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy:results from SEARCH database. J Urol 2003;169:2136-2141. (Pubitemid 36576734)
8. Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 2004;172;137-140.
9. Ravery V, Chastang C, Toublanc M, Boccon-Gibod L, Delmas V, Boccon-Gibod L. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol 2000;37:449-455. (Pubitemid 30157807)
10. Igdem S, Abacioglu U, Cetin I et al. Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation. J BUON 2009;14:629-634.
11. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003;169:157-163. (Pubitemid 35461577)
12. D'Amico AV, Whittington R, Malkowicz SB et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999;17:168-172. (Pubitemid 29022390)
13. Tombal B, Querton M, de Nayer P et al. Free/total PSA ratio does not improve prediction of pathological stage and biochemical recurrence after radical prostatectomy. Urology 2002;59:256-260. (Pubitemid 34134527)
14. Chun FK, Steuber T, Erbersdobler A et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49:820-826.
15. Winkler MH, Khan FA, Kulinskaya E et al. The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy. BJU Int 2004;94;812-815. (Pubitemid 39472475)